New Clinical Data on OPKO Health’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023
02 nov. 2023 10h00 HE
|
OPKO Health, Inc.
MIAMI, Nov. 02, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) presented late-breaking clinical data on RAYALDEE® extended-release calcifediol (ERC) at the American Society of Nephrology...
OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023
31 oct. 2023 08h00 HE
|
OPKO Health, Inc.
MIAMI, Oct. 31, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and nine months ended September 30, 2023 after the close of the...
OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023
25 oct. 2023 16h25 HE
|
OPKO Health, Inc.
MIAMI, Oct. 25, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) will present late-breaking clinical data on RAYALDEE® extended-release calcifediol (ERC) at the American Society of...
ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats
28 sept. 2023 16h08 HE
|
OPKO Health, Inc.
NATICK, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health, Inc. company (NASDAQ: OPK), has been awarded a contract from the Biomedical Advanced Research and...
OPKO Health Reports Second Quarter 2023 Business Highlights and Financial Results
03 août 2023 16h05 HE
|
OPKO Health, Inc.
MIAMI, Aug. 03, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2023. Second quarter business...
OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023
25 juil. 2023 16h05 HE
|
OPKO Health, Inc.
MIAMI, July 25, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2023 after the close of the U.S....
OPKO Health Reports First Quarter 2023 Business Highlights and Financial Results
03 mai 2023 16h05 HE
|
OPKO Health, Inc.
MIAMI, May 03, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2023. First quarter business...
OPKO Health to Report First Quarter 2023 Financial Results on May 3, 2023
25 avr. 2023 16h05 HE
|
OPKO Health, Inc.
MIAMI, April 25, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2023 after the close of the U.S....
OPKO Health to Hold Virtual R&D Day on March 20, 2023
09 mars 2023 08h00 HE
|
OPKO Health, Inc.
MIAMI, March 09, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that it will hold an R&D Day event on March 20, 2023 beginning at 4:00 p.m. Eastern time. The two-hour...
OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate
08 mars 2023 08h00 HE
|
OPKO Health, Inc.
MDX-2201 leverages ModeX’s innovative biologics platform to target multiple Epstein-Barr virus (EBV) proteinsEBV is the leading cause of infectious mononucleosis and is also associated with some...